Back to results
US 6,716,825 B2Granted
Phosphonate compounds
AssigneeThe Regents of the University of California
InventorsKarl Y. Hostetler, James R. Beadle, Ganesh D. Kini
Life of this patent
Estimating the term…
Abstract
The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorder, e.g., osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like.
Claims15
A phosphonate compound having the structure:
- wherein:
- R1 and R1′ are independently —H, optionally substituted —O(C1-C24)alkyl, —O(C1-C24)alkenyl, —O(C1-C24)acyl, —S(C1-C24)alkyl, —S(C1-C24)alkenyl, or —S(C1-C24)acyl, wherein at least one of R1 and R1′ are not —H, and wherein said alkenyl or acyl optionally have 1 to about 6 double bonds,
- R2 and R2′ are independently —H, optionally substituted —O(C1-C7)alkyl, —O(C1-C7)alkenyl, —S(C1-C7)alkyl, —S(C1-C7)alkenyl, —O(C1-C7)acyl, —S(C1-C7)acyl, —N(C1-C7)acyl, —NH(C1-C7)alkyl, —N((C1-C7)alkyl)2, oxo, halogen, —NH2, —OH, or —SH;
- R3 is a phosphonate derivative of a pharmacologically active compound linked to a functional group on optional linker L or to an available oxygen atom on Cα;
- X, when present, is:
- L is a valence bond or a bifunctional linking molecule of the formula —J—(CR2)t—G—, wherein t is an integer from 1 to 24, J and G are independently —O—, —S—, —C(O)O—, or —NH—, and R is —H, substituted or unsubstituted alkyl, or alkenyl;
- m is an integer from 0 to 6;
- and
- n is 0 or 1.
6 more elements
Dependencies are inferred from the claim text.